Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion T.S. Walsh, J. Palmer, D. Watson, K. Biggin, M. Seretny, H. Davidson, M. Harkness, A. Hay British Journal of Anaesthesia Volume 108, Issue 1, Pages 63-71 (January 2012) DOI: 10.1093/bja/aer326 Copyright © 2012 The Author(s) Terms and Conditions
Fig 1 Description of study cohort according to the use of cell salvage and associated use of red cells at different stages of the perioperative period. RBC, red blood cell. *Six of 210 (2.9%) patients had unknown cell salvage status. **One of 73 patients was transfused with 4 allogeneic red cell units but timing in relation to surgery was not documented. †Four of 88 patients had an unknown re-infusion volume. #Eight (3.8%) patients received postoperative cell salvage in four centres. British Journal of Anaesthesia 2012 108, 63-71DOI: (10.1093/bja/aer326) Copyright © 2012 The Author(s) Terms and Conditions
Fig 2 Distribution of re-infusion volumes for the 68 patients who received PCS with re-infusion. British Journal of Anaesthesia 2012 108, 63-71DOI: (10.1093/bja/aer326) Copyright © 2012 The Author(s) Terms and Conditions